Hyderabad: The 23rd edition of BioAsia 2026, touted as Asia’s leading life sciences and healthcare conclave, is set to take place in Hyderabad on February 17–18, 2026. The event will bring together a host of global scientific leaders, artificial intelligence (AI) pioneers, pharma and biotech industry CEOs, and policymakers. This year’s theme, “TechBio Unleashed: AI, Automation & the Biology Revolution,” will focus on the intersection of AI, advanced biology, and intelligent manufacturing, emphasizing their collective impact on the discovery, development, and delivery of therapies worldwide.
The conference comes at a significant juncture, following the Telangana government’s unveiling of its new life sciences policy for 2026–30 at the World Economic Forum in Davos. The event will be inaugurated by A Revanth Reddy, the Chief Minister of Telangana, alongside D Sridhar Babu, the Minister for Industries and IT. This gathering coincides with the state government’s ambition to establish Hyderabad among the top five life sciences hubs globally.
In addition to the overall theme, a dedicated session titled “Telangana Rising Vision 2047” will outline the state’s roadmap for innovation-led growth, focusing on advanced therapeutic modalities, AI-enabled research and development, and next-generation biomanufacturing. The session aims to highlight how the state is positioning itself as a leader in the life sciences sector.
Among the prominent speakers scheduled to present at the conference is Dr Stefan Miltenyi, founder and President of Miltenyi Biotec, who will discuss next-generation biologics from discovery through scalable chemistry, manufacturing, and controls (CMC). Dr Howard Y Chang, Chief Scientific Officer at Amgen, will address AI-powered biology for target discovery and precision medicine. Meanwhile, Pushmeet Kohli, Vice President of Science at Google DeepMind, will delve into foundational models and breakthroughs in protein science that are accelerating biomedical discovery.
The second day of the conference will feature a plenary address by Madeleine Roach, Executive Vice President and head of business operations at Sanofi, who will share insights on the company’s AI-first transformation across research and development and manufacturing. Additionally, there will be discussions on the emergence of life sciences global capability centers in India, which are becoming pivotal innovation engines with tangible impacts on patient care.
Other notable speakers include Anton Groom, Chief AI Officer at MSD; Despina Solomonidou, Executive Vice President and global head of technical research and development at Novartis; Rashmi Kumar, Senior Vice President and CIO at Medtronic; Eamonn Warren, Group Vice President of manufacturing at Eli Lilly; and Badhri Srinivasan, Group CEO of Unilabs.
Over the course of nine sessions and a marquee CEO Conclave, the discussions will cover a wide array of topics, including scaling innovation across science, software, and supply chains, as well as identifying sector headwinds and growth drivers through 2030. The role of AI in contract research, development, manufacturing organizations (CRDMOs), and biomanufacturing will also be a focal point.
BioAsia 2026 is positioned to be a significant event in the life sciences calendar, reflecting the increasing convergence of technology and biology, and offering insights into how these advancements could reshape the future of healthcare and life sciences globally. With an impressive lineup of speakers and a robust agenda, the conference will undoubtedly play a crucial role in fostering innovation and collaboration in this rapidly evolving field.
For more information, visit the official BioAsia website at BioAsia and stay updated on the latest developments in the life sciences sector.
See also
Korea’s AI Privacy Council Launches to Redefine Data Governance for Autonomous Systems
AI in Construction Market Projected to Surge to $15.88B by 2032, Driven by Smart Tech Adoption
Voxtral Launches Transcribe 2 with 13-Language Support and Sub-200ms Latency
IBM Secures $151B Defense Contract, Signals AI-Driven Workforce Transformation
